Regeneron Pharmaceuticals Inc. buy Morgan Stanley
Start price
01.11.24
/
50%
€779.00
Target price
01.11.25
€1,092.0
Performance (%)
-34.04%
Price
13:58
€511.20
Summary
This prediction is currently active. Massive losses of -34.04% have been the result for the BUY prediction by Morgan_Stanley. A total of €2.60 was paid as dividends for this prediction. This prediction currently runs until 01.11.25. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Regeneron Pharmaceuticals Inc. | 2.893% | 2.893% |
| iShares Core DAX® | -0.545% | -0.397% |
| iShares Nasdaq 100 | 0.626% | 1.990% |
| iShares Nikkei 225® | -1.750% | 3.455% |
| iShares S&P 500 | 0.882% | 2.156% |
Comments by Morgan_Stanley for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its price target lowered by analysts at Morgan Stanley from $1,235.00 to $1,184.00. They now have an "overweight" rating on the stock.
Ratings data for REGN provided by MarketBeat
Stopped prediction by Morgan_Stanley for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€479.90
10.07.25
10.07.25
€642.11
10.07.26
10.07.26
6.71%
13:58
13:58
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€428.20
02.06.25
02.06.25
€664.02
02.06.26
02.06.26
19.59%
13:58
13:58
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€995.00
11.07.24
11.07.24
€1,087.6
11.07.25
11.07.25
-51.07%
12.07.25
12.07.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€883.50
18.03.24
18.03.24
€1,025.4
18.03.25
18.03.25
-30.96%
19.03.25
19.03.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€764.50
03.11.23
03.11.23
€854.04
03.11.24
03.11.24
1.87%
04.11.24
04.11.24
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€785.00
11.10.23
11.10.23
€861.38
11.10.24
11.10.24
17.78%
12.10.24
12.10.24
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€692.50
04.08.23
04.08.23
€828.28
04.08.24
04.08.24
42.96%
05.08.24
05.08.24